132
Participants
Start Date
July 31, 2004
Primary Completion Date
May 31, 2009
Study Completion Date
June 30, 2009
Placebo
Placebo will be administered by slow intravenous infusion once daily for 14 days.
GM-CSF
Recombinant human GM-CSF (250 mcg/M2) will be administered by slow intravenous infusion once daily for 14 days.
Emory University, Atlanta
University of Michigan, Ann Arbor
University of Colorado Health Sciences Center, Denver
National Heart, Lung, and Blood Institute (NHLBI)
NIH
Emory University
OTHER
University of Colorado, Denver
OTHER
University of Michigan
OTHER